Bristol Myers Squibb Co. has appointed Cari Gallman as the new Executive Vice President, General Counsel, and Chief Policy Officer, marking a significant leadership shift as the pharmaceutical giant navigates complex litigation challenges. The transition, detailed in a recent announcement, follows the impending retirement of Sandra Leung after a notable 33-year tenure at the company.
Gallman, previously serving as the Executive Vice President for Corporate Affairs, steps into her new role during a pivotal time for Bristol Myers Squibb. The company is currently engaged in a high-stakes legal battle with the federal government over rebates related to its flagship drug, Eliquis. This case underscores the critical nature of the legal acumen required in her new position.
With an impressive track record that includes roles such as Senior Vice President, Chief Compliance and Ethics Officer, and Vice President, Assistant General Counsel for Oncology at Bristol Myers Squibb, Gallman is well-prepared to lead the company’s legal and policy strategies.
Her extensive company experience and prior work as a Litigation Associate at Debevoise & Plimpton, coupled with her educational background from Harvard Law School, equip her with the necessary skills and knowledge to guide Bristol Myers Squibb through its current legal hurdles.
The leadership change was communicated internally by CEO Chris Boerner, and the transition plan includes a phase where Sandra Leung will remain to assist Gallman, ensuring a seamless handover of responsibilities. The duration of this transition period has not been disclosed, highlighting the strategic planning behind the executive changes.
This leadership update comes at a crucial moment for Bristol Myers Squibb, emphasizing the integration of corporate affairs with legal and policy responsibilities. Gallman’s promotion is seen as a strategic move to strengthen the company’s position in dealing with ongoing and future regulatory challenges.
For more details on Gallman's appointment and the company’s legal strategies moving forward, the original announcement can be found on Bloomberg Law.
